Literature DB >> 18525333

Rapid evolution of the biology and treatment of sarcoma.

Jonathan C Trent1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18525333     DOI： 10.1097/CCO.0b013e328303ba31

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN： 1040-8746            Impact factor:   3.645


× No keyword cloud information.
  3 in total

1.  Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.

Authors:  Zhenfeng Duan; Edwin Choy; David Harmon; Cao Yang; Keinosuke Ryu; Joseph Schwab; Henry Mankin; Francis J Hornicek
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

2.  Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines.

Authors:  Cao Yang; Edwin Choy; Francis J Hornicek; Kirkham B Wood; Joseph H Schwab; Xianzhe Liu; Henry Mankin; Zhenfeng Duan
Journal:  Anticancer Res       Date:  2011-04       Impact factor: 2.480

3.  Role of relaxin-2 in human primary osteosarcoma.

Authors:  Jinfeng Ma; Min Niu; Wenjiu Yang; Lina Zang; Yongming Xi
Journal:  Cancer Cell Int       Date:  2013-06-10       Impact factor: 5.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.